Brian Keegan

Vaccination of Monkeys with Recombinant<i>Plasmodium falciparum</i>Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria

Anthony W. Stowers, Michael Kennedy, Brian Keegan et al. · Infection and Immunity · 2002 · 174 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunity to Recombinant<i>Plasmodium falciparum</i>Merozoite Surface Protein 1 (MSP1): Protection in<i>Aotus nancymai</i>Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity

Sanjay Singh, Kazutoyo Miura, Hong Zhou et al. · Infection and Immunity · 2006 · 146 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg et al. · Human Vaccines & Immunotherapeutics · 2021 · 100 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

An enzymatically inactivated hemoglobinase from <i>Necator americanus</i> induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection

Mark S. Pearson, Jeffrey M. Bethony, Darren Pickering et al. · The FASEB Journal · 2009 · 89 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Wen‐Hsiang Chen, Junfei Wei, Rakhi Kundu et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2021 · 71 citations · Full text

Life Sciences, Biomolecular Engineering, Infectious Diseases +14